Our Programs

Earle A. Chiles Research Institute

The Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute is a world-class research facility located within Providence Cancer Center in Portland, OR

Providence Cancer Center

At Providence Cancer Center, we work together to give patients and families the best care on the West Coast. We partner with them from diagnosis and treatment through all the stages of life, ensuring an excellent patient experience and seeking the best outcomes through research and innovation.

Providence Cancer Center for Clinicians

At Providence Cancer Center, patients and families benefit from some of the finest, most comprehensive cancer services in the world, including the...

Providence Colorectal Cancer Program

Providence Colorectal Cancer Surgery Program offers state-of-the-art diagnostic and minimally-invasive surgical options for patients with colon cancer, rectal cancer, and cancer of the intestinal tract, anus or peri-anal area. The program also offers services for anal dysplasia.

Providence Hematologic Malignancies Program

Hematologic malignancies include Hodgkin and non-Hodgkin lymphomas, leukemias, myeloma and the myelodysplastic syndromes. These malignancies are...

Providence Hepatobiliary and Pancreatic Cancer Program

Providence Hepatobiliary and Pancreatic Cancer Program serves patients with liver and pancreatic diseases including disorders of the liver, bile...

Providence Immunotherapy Program

Immunotherapy at Providence As the body’s natural defense system, the immune system hunts down and destroys harmful invaders, such as...

Providence Melanoma Program

Providence doctors and scientists have been leading the way in melanoma research and treatment. Our findings have resulted in new ways to boost immune response, improving the standard of care for patients with this aggressive malignancy.

The Gamma Knife Center of Oregon

Gamma Knife is the most advanced radiosurgical tool available to treat a variety of brain lesions and disorders, including cancers of the brain.